Workshops

Pharmaceutical promotion is no longer limited to sales representatives. Today, speakers, digital platforms, influencers, key opinion leaders, and even AI-driven clinical tools are shaping how information about therapies reaches healthcare professionals and patients. As these channels multiply, so do the regulatory questions around agency, promotional responsibility, disclosure, and oversight.

This session explores how regulators may view these emerging actors and offers practical guidance for companies navigating the next phase of pharmaceutical promotion.

If your company operates in the United States, you know that no two states approach pharmaceutical distribution licensing exactly the same way. Navigating those differences and understanding how they apply to your specific business model can be challenging.

In this workshop, we’ll decode the differences between various license types — such as distributor, wholesaler, and virtual manufacturer — and offer practical guidance to help you determine which licenses may be relevant for your organization’s structure and activities.

This is a highly interactive session that offers a valuable forum for discussing challenges and exchanging ideas. Bring your questions and experiences, and leave with practical tips and real-world perspectives. Whether you’re new to licensing or looking to broaden your knowledge, this workshop will give you clearer insight into the complexities of pharmaceutical state licensing.

Managing a sample compliance program means navigating complex relationships across internal departments, external vendors, and competing priorities. When one of those elements falls out of alignment, the entire program feels it.

This workshop cuts through that complexity, covering what a healthy program actually looks like, how to design one that functions across departments and external service providers, and how to manage vendor partnerships effectively. It also tackles the often-overlooked human side of compliance — building a culture of accountability without creating friction.

Attendees will work through real-world case studies before engaging in an interactive component, where they bring their toughest cross-functional or vendor challenge and leave with a practical framework for resolving it.

Launching a new pharma sales team is high stakes. Sales Operations leaders are under constant pressure to ensure new reps are fully compliant, operationally ready, and able to hand-sample in their local markets as soon as training is complete – often within a matter of weeks. Yet the operational reality on the ground frequently creates delays: locating compliant storage, ensuring state specific readiness, coordinating across vendors, and managing inconsistencies market by market.

This session will examine real-world frameworks and strategies for ensuring sales teams are ready to hand-sample immediately after training and across diverse local markets.

Presenters will highlight the operational best practices, decision points, and common pitfalls Sales Operations leaders should be addressing before reps ever enter the field. The session also covers how to align compliance and logistics, eliminate last mile bottlenecks that impact productivity, and create a standardized playbook for rapid, repeatable onboarding and expansion.

Attendees can expect to gain actionable tips, valuable lessons, and compliance-focused strategies they can put to work right away. This session is perfect for Sales Operations, Sample Operations, and Commercial leaders seeking a faster, simpler path to field readiness without adding extra operational complexity.

HCP engagement is evolving rapidly, and traditional sampling models can no longer keep up. To build true connections, brands must rethink their approach and embrace new, flexible strategies that meet HCPs where they are.

This workshop examines how forward-thinking, adaptable strategies are redefining brand connections, from energetic congress kiosks to mobile, on-the-go approaches. You’ll discover practical ways to reach HCPs directly in their workflow, streamline the sampling process, and sustain authentic, brand-forward engagement at every touchpoint.

Gain actionable insights on orchestrating cross-vendor collaboration, navigating complex budgets, and maintaining compliance, all while delivering real impact. You’ll also discover proven strategies for launching innovative, scalable sampling programs that captivate HCPs, expand your brand’s reach, and drive measurable results.

Join us for this critical workshop by securing your spot at the Sharing Conference!

The Drug Supply Chain Security Act, or the DSCSA, is a federal law that grants the FDA authority to establish regulations aimed at preventing harmful drug products from entering the US supply chain – and detecting and removing them if they do. Under the act, all eligible trading partners must implement an electronic, interoperable system to identify and trace prescription drugs at the package level throughout the supply chain. While the DSCSA strengthens supply chain security and patient safety, it also brings operational challenges and new compliance demands.

Join us for this essential workshop to gain practical strategies for DSCSA compliance. We’ll break down all five sections of the law and explore key topics, including:

• Authorized Trading Partners
• Labeling Requirements of Drug Products Distributed Under DSCSA
• Covered Transactions and Product Tracing Information
• Suspect and Illegitimate Products
• Record Retention Requirements

We’ll also touch on the FDA’s final rule standardizing the National Drug Code (NDC) to a uniform 12-digit format, providing an overview of implementation timelines and compliance requirements. As a core component of the product identifier required under the DSCSA, this is a critical topic all compliance professionals must master.

Bring your DSCSA and NDC questions, and leave with actionable solutions you can implement right away.